Actividades asistenciales

ARTIFICIAL IMMUNE RECEPTORS
12/12/2024 - The present disclosure provides novel polypeptides, so called artificial immune receptors or AlRs, that are novel tools for cellular therapies. AIR-expressing regulatory T cells sense these...
COMBINATION THERAPY COMPRISING SIRP ALPHA FUSION PROTEIN AND ANTI-CD19 ANTIBODY FOR TREATMENT OF CANCER
12/12/2024 - Combination therapies comprising a SIRPaFc fusion protein and an anti-CD19 agent are provided. The combination therapies can optionally further include an E3 ubiquitin ligase modulator.
AZETIDINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, PREPARATION METHODS AND THEIR USES IN THE TREATMENT OF CNS DISORDERS
12/12/2024 - The present disclosure relates to compounds of formula (I) and stereoisomers and pharmaceutically acceptable salts thereof, wherein R
STABLE CANNABINOID FORMULATIONS
12/12/2024 - Abstract The present invention is generally directed to substantially pure cannabidiol, stable cannabinoid pharmaceutical formulations, and methods of their use. -91-
COMPOSITIONS AND METHODS FOR TREATING MYELIN DISORDERS
12/12/2024 - A method of enhancing oligodendrocyte progenitor cell (OPC) migration, differentiation, proliferation and/or maturation in a subject in need thereof includes administering to the subject a...
NUTRITIONAL COMPOSITION FOR NEURODEGENERATION AND NEUROTRAUMA
12/12/2024 - The invention relates to a nutritional composition comprising a combination of (i) omega-3 fatty acid DHA with (ii) vitamin B2 and (iii) vitamin D3 for use in the treatment of neurodegenerative...
CD98 BINDING CONSTRUCTS FOR TREATING BRAIN TUMORS
06/11/2024 - Se proporcionan nuevos anticuerpos multiespecíficos que comprenden al menos una de una primera región de unión al antígeno y una segunda región de unión al antígeno cada una capaz de unirse...
MACROCYCLIC OREXIN RECEPTOR AGONISTS AND USES THEREOF
12/12/2024 - Provided herein are compounds of Formula (I), (I), or pharmaceutically acceptable salt thereof, wherein m, n, p, A